Changing Landscape of Congenital Heart Disease
Изменяющийся ландшафт врождённых пороков сердца
2017-03-16
SCID: 54.1/wrgwdpq9
Discuss with AI
adult congenital heart diseasecardiopulmonary bypasscatheter-based interventionscongenital heart diseasemultidisciplinary care
Figures from the paper
Abstract (AI)
Congenital heart disease is the most frequently occurring congenital disorder affecting ≈0.8% of live births. Thanks to great efforts and technical improvements, including the development of cardiopulmonary bypass in the 1950s, large-scale repair in these patients became possible, with subsequent dramatic reduction in morbidity and mortality. The ongoing search for progress and the growing understanding of the cardiovascular system and its pathophysiology refined all aspects of care for these patients. As a consequence, survival further increased over the past decades, and a new group of patients, those who survived congenital heart disease into adulthood, emerged. However, a large range of complications raised at the horizon as arrhythmias, endocarditis, pulmonary hypertension, and heart failure, and the need for additional treatment became clear. Technical solutions were sought in perfection and creation of new surgical techniques by developing catheter-based interventions, with elimination of open heart surgery and new electronic devices enabling, for example, multisite pacing and implantation of internal cardiac defibrillators to prevent sudden death. Over time, many pharmaceutical studies were conducted, changing clinical treatment slowly toward evidence-based care, although results were often limited by low numbers and clinical heterogeneity. More attention has been given to secondary issues like sports participation, pregnancy, work, and social-related difficulties. The relevance of these issues was already recognized in the 1970s when the need for specialized centers with multidisciplinary teams was proclaimed. Finally, research has become incorporated in care. Results of intervention studies and registries increased the knowledge on epidemiology of adults with congenital heart disease and their complications during life, and at the end, several guidelines became easily accessible, guiding physicians to deliver care appropriately. Over the past decades, the landscape of adult congenital heart disease has changed dramatically, which has to be continued in the future.
Key Findings
1
Adults with congenital heart disease face important late complications, including arrhythmias, endocarditis, pulmonary hypertension, and heart failure.
2
Advances including cardiopulmonary bypass and improved surgical care dramatically reduced morbidity and mortality, substantially increasing long-term survival.
3
Care has expanded beyond open surgery to catheter-based interventions, advanced electronic devices, multidisciplinary specialized centers, evidence-based treatment, and guideline-supported lifelong management.
4
Congenital heart disease affects approximately 0.8% of live births, making it the most frequent congenital disorder.
5
Improved survival created a growing adult congenital heart disease population requiring lifelong monitoring and specialized care.
6
Research, intervention studies, and registries have improved understanding of adult congenital heart disease epidemiology and complications, although pharmaceutical evidence remains limited by small samples and clinical heterogeneity.
Research Object
patients with congenital heart disease, particularly adults who survived into adulthood
Research Subject
the changing long-term clinical care, complications, outcomes, and management needs of congenital heart disease across the transition to adulthood
Publication Details
Publication Date
2017-03-16
Journal
Publisher
ISSN
Cited by
461
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest